7 completed, 5 unknown, 1 not yet recruiting, 1 recruiting. 6 Not applicable, 5 Phase 2, 4 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 4, Unknown 1, Withdrawn 1 |
| Phase 2 | 5 | Unknown 4, Completed 1 |
| Phase 3 | 4 | Unknown 2, Completed 1, Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Prevention & Control: new trials by email Literature Review of Prevention & Control trials Research Report on Prevention & Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis Rosuvastatin 20 Mg Oral Tablet, Colchicine 0.5 MG Oral Tablet Once Daily, Placebo - Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression | Phase 3 | Recruiting | Duke University | 1500 | 2026-07-21 | 2026-10-07 |
| Impact of Prevention of Safe Sleeping and Unexpected Infant Death Sleeping mode - Unexpected Infant Death, Prevention & Control | Not yet recruiting | University Hospital, Angers | 100 | 2025-11-30 | 2025-11-19 | |
| Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children Bovine colostrum, Placebo - Urinary Tract Infections, Recurrent | Phase 2 | Completed | Ain Shams University | 60 | 2023-06-01 | 2026-01-02 |
| Substantivity of Oral Rinses: Comparative Study Oral rinse, Saliva harvest - Prevention & Control | Not applicable | Completed | University of Barcelona | 16 | 2022-01-01 | 2022-05-11 |
| Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM) Hydroxychloroquine Only Product in Oral Dose Form - Sars-CoV2, Coronavirus Infection | Phase 2 / Phase 3 | Unknown | University of Malaga | 1930 | 2020-09-01 | 2020-09-29 |
| Effects Provided by a Physiotherapy Treatment Preventing Lower Extremity Injuries in Female Football Players Physiotherapy program of lumbopelvic stabilization and strengthening of the hip region musculature - Anterior Cruciate Ligament Injuries, Injuries, Knee | Not applicable | Unknown | Universidad de Zaragoza | 35 | 2019-09-09 | 2019-09-04 |
| S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections drug product: capsules are containing S. boulardii, administered twice daily (250 mg) - Prevention & Control, Diarrhea Caused by Drug | Phase 4 | Completed | Clinical Centre of Serbia | 96 | 2017-11-01 | 2022-03-02 |
| Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy EGCG, mLDG - Lung Neoplasms, Esophagitis | Phase 2 | Unknown | Shandong Cancer Hospital and Institute | 83 | 2015-04-01 | 2020-04-28 |
| Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy EGCG, placebo - Breast Neoplasms, Dermatitis | Phase 2 | Unknown | Shandong Cancer Hospital and Institute | 68 | 2014-12-01 | 2019-04-05 |
| Cohort Study of Risk Reducing Salpingectomy Salpingectomy, Traditional sterilization - Sterilization, Tubal, Salpingectomy | Not applicable | Completed | University of North Carolina, Chapel Hill | 18 | 2014-06-01 | 2017-04-25 |
| Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease Rivaroxaban (Xarelto, BAY59-7939), Aspirin, Aspirin placebo - Prevention & Control | Phase 3 | Completed | Bayer | 27395 | 2013-02-28 | 2022-11-28 |
| Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients Trimethoprim/Sulfamethoxazole - Pneumonia, Pneumocystis, Prevention & Control | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 80 | 2012-08-01 | 2012-12-11 |
| Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever APAP and NAC combination, APAP and Placebo - Liver Failure, Liver Failure, Acute | Not applicable | Withdrawn | Columbia University | 2009-04-01 | 2015-03-05 | |
| Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders Educational outreach - Colorectal Cancer Screening, Prevention & Control | Not applicable | Completed | Northwestern University | 628 | 2008-10-01 | 2011-12-01 |
| KAN-DO: A Family-based Intervention to Prevent Childhood Obesity KAN-DO - Obesity, Prevention & Control | Not applicable | Completed | Duke University | 832 | 2007-10-01 | 2014-07-11 |
Angina Pectoris (1) · Anterior Cruciate Ligament Injuries (1) · Breast Neoplasms (1) · COVID-19 (1) · Chemical and Drug Induced Liver Injury (1) · Communicable Diseases (1) · Coronary Artery Disease (1) · Coronavirus Infections (1) · Dermatitis (1) · Esophagitis (1) · Fever (1) · Heart Diseases (1) · Infections (1) · Knee Injuries (1) · Liver Failure (1)
Pathological Conditions, Signs and Symptoms (4) · Lung Diseases (3) · Respiratory Tract Diseases (3) · Signs and Symptoms (3) · Digestive System Diseases (2) · Infections (2) · Neoplasms (2) · Neoplasms by Site (2) · Pathologic Processes (2) · Pneumonia (2) · Respiratory Tract Infections (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Bacterial Infections and Mycoses (1)
Dosage Forms (2) · Acetaminophen (1) · Acetylcysteine (1) · Aspirin (1) · Colchicine (1) · Mouthwashes (1) · Pantoprazole (1) · Rivaroxaban (1) · Rosuvastatin Calcium (1) · Salpingectomy (1) · Tablets (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
Duke University (2) · Shandong Cancer Hospital and Institute (2) · Ain Shams University (1) · Bayer (1) · Clinical Centre of Serbia (1) · Columbia University (1) · Northwestern University (1) · Peking Union Medical College Hospital (1) · Universidad de Zaragoza (1) · University Hospital, Angers (1) · University of Barcelona (1) · University of Malaga (1) · University of North Carolina, Chapel Hill (1)
United States (6) · China (2) · France (2) · Spain (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · Colombia (1) · Czechia (1) · Denmark (1) · Ecuador (1) · Egypt (1)
Ligang Xing, MD,PhD (2) · Branislava Milenkovic, Prof, MD (1) · Cheryl Lovelady, PhD, RD (1) · Fengchun Zhang, MD (1) · Juan C Morilla-Herrera, PhD (1) · Kenzie A Cameron, PhD, MPH (1) · Matthew Chang, MD (1) · Matthew L Zerden, MD, MPH (1) · Truls Ostbye, MD PhD (1)
PMID 21149742, PMID 22705016, PMID 23736357, PMID 28754388, PMID 28844176, PMID 28844192, PMID 29132877, PMID 29132879, PMID 29132880, PMID 29186454, PMID 29346127, PMID 29372976, PMID 29540326, PMID 29661947, PMID 29945212, PMID 30058959, PMID 30213508, PMID 30220379, PMID 30354448, PMID 30417662, PMID 30538057, PMID 30654882, PMID 30667279, PMID 30702997, PMID 30916315, PMID 31054846, PMID 31072566, PMID 31144674, PMID 31146821, PMID 31152740, PMID 31163978, PMID 31248548, PMID 31248549, PMID 31321405, PMID 31358978, PMID 31504399, PMID 31510769, PMID 31524941, PMID 31537259, PMID 31615291, PMID 31715433, PMID 31807773, PMID 32178526, PMID 32223318, PMID 32289159, PMID 32436455, PMID 32651298, PMID 32951537, PMID 32997098, PMID 33538248
UG3HL181434 (1)